Enovis Corp.

  • Market Cap: Small Cap
  • Industry: Industrial Manufacturing
  • ISIN: US1940145022
USD
27.96
-1.42 (-4.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Enovis Corp. stock-summary
stock-summary
Enovis Corp.
Industrial Manufacturing
Colfax Corporation is a technology company. The Company provides orthopedic care and fabrication technology products and services. It operates through two segments: Fabrication Technology and Medical Technology. Fabrication Technology segment is a supplier of welding equipment, cutting equipment, automated welding and cutting systems, and consumables. Medical Technology segment is a provider of orthopedic solutions, providing orthopedic devices, software and services. Its fabrication technology products are marketed under the ESAB brand. ESAB's range of cutting and welding consumables includes electrodes, cored and solid wire and fluxes. The Company, through its subsidiary DJO Global, Inc. (DJO), provides medical devices that provide solutions for musculoskeletal health, vascular health and pain management. It offers products under various brands, including Aircast, Chattanooga, Regeneration, COMPEX, DJO Surgical, DONJOY, DR.COMFORT, PROCARE, Bell-Horn, Exos, Fast Freeze and Saunders.
Company Coordinates stock-summary
Company Details
420 National Business Pkwy Fl 5 , ANNAPOLIS JUNCTION MD : 20701-1079
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 95 Schemes (66.44%)

Foreign Institutions

Held by 126 Foreign Institutions (9.81%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Mitchell Rales
Chairman of the Board
Mr. Matthew Trerotola
President, Chief Executive Officer, Director
Mr. Patrick Allender
Presiding Independent Director
Mr. Thomas Gayner
Independent Director
Ms. Rhonda Jordan
Independent Director
Mr. Liam Kelly
Independent Director
Mr. A. Clayton Perfall
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
565 Million
(Quarterly Results - Jun 2025)
Net Profit:
-36 Million
stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

USD 1,795 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.53

stock-summary
Return on Equity

-3.40%

stock-summary
Price to Book

0.70